TrialCancer medicine2023

Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Laurent Zelek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.